- Home
- BMRN vs FIG Comparison
BMRN vs FIG Comparison
Compare BMRN & FIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMRN | FIG |
|---|---|---|
| Founded | 1996 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3B | 11.9B |
| IPO Year | 1999 | 2025 |
Fundamental Metrics
Financial Performance| Metric | BMRN | FIG |
|---|---|---|
| Price | $59.87 | $20.83 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 18 | 13 |
| Target Price | ★ $88.22 | $50.50 |
| AVG Volume (30 Days) | 1.7M | ★ 11.2M |
| Earning Date | 05-04-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 0.80 |
| EPS | ★ 0.77 | N/A |
| Revenue | ★ $1,313,646,000.00 | $1,055,788,000.00 |
| Revenue This Year | $15.02 | $31.18 |
| Revenue Next Year | $12.23 | $20.22 |
| P/E Ratio | $77.32 | ★ N/A |
| Revenue Growth | 17.62 | ★ 40.96 |
| 52 Week Low | $49.26 | $16.60 |
| 52 Week High | $70.98 | $71.41 |
Technical Indicators
Market Signals| Indicator | BMRN | FIG |
|---|---|---|
| Relative Strength Index (RSI) | 31.36 | 36.10 |
| Support Level | $58.03 | $19.88 |
| Resistance Level | $60.36 | $21.48 |
| Average True Range (ATR) | 1.43 | 1.08 |
| MACD | -0.71 | -0.31 |
| Stochastic Oscillator | 9.83 | 19.60 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About FIG Figma Inc.
Figma provides software solutions for design-related workflows. Since its founding in 2015, the company has introduced a variety of products and established an end-to-end platform for software design and product development. The firm's original and most important solution, Figma Design, was built as a collaborative tool to bring together designers and engineers in a real-time, multiple-simultaneous-editor workspace. Figma is headquartered in San Francisco, California, and completed its IPO in July 2025.